Palatin Technologies (NYSEAMERICAN:PTN) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Palatin Technologies (NYSEAMERICAN:PTNGet Free Report) announced its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.03), RTT News reports. Palatin Technologies had a negative net margin of 445.12% and a negative return on equity of 583.06%. During the same period in the prior year, the firm earned ($0.63) earnings per share.

Palatin Technologies Stock Down 1.0 %

Shares of Palatin Technologies stock opened at $2.02 on Friday. Palatin Technologies has a twelve month low of $1.43 and a twelve month high of $5.65.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “buy” rating and issued a $17.00 price target on shares of Palatin Technologies in a report on Wednesday.

Read Our Latest Report on Palatin Technologies

About Palatin Technologies

(Get Free Report)

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.

Read More

Earnings History for Palatin Technologies (NYSEAMERICAN:PTN)

Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.